AI
Tuesday, February 21, 2017 3:38:50 PM
@ ramad
I touched on this in a previous post. To hire a company to manage the testing is expensive. Paying patients is also expensive. They did have a small company in place testing frequently, but not for the announcement we are waiting for. They must have done a dozen or so. My wife was one. They were working on the protocol and then a month or so later we went on min. wage. Echo didn't pay that company for sure. So everything halted.
In the real world, you do NOT have to have a finished product, but you have to be on a stable baseline in terms of components and software. Software and other components would go out as a clinical testing release and trials would commence. While running the trial, you can't introduce changes. You can theoretically find bugs and fix them later. If changes are required, you would make the changes and freeze the version again. You have to restart the trial. This is EXPENSIVE... so better to get it damn near perfect the first time
I touched on this in a previous post. To hire a company to manage the testing is expensive. Paying patients is also expensive. They did have a small company in place testing frequently, but not for the announcement we are waiting for. They must have done a dozen or so. My wife was one. They were working on the protocol and then a month or so later we went on min. wage. Echo didn't pay that company for sure. So everything halted.
In the real world, you do NOT have to have a finished product, but you have to be on a stable baseline in terms of components and software. Software and other components would go out as a clinical testing release and trials would commence. While running the trial, you can't introduce changes. You can theoretically find bugs and fix them later. If changes are required, you would make the changes and freeze the version again. You have to restart the trial. This is EXPENSIVE... so better to get it damn near perfect the first time
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
